Sg Americas Securities, LLC I Mab Transaction History
Sg Americas Securities, LLC
- $24.4 Billion
- Q4 2024
A detailed history of Sg Americas Securities, LLC transactions in I Mab stock. As of the latest transaction made, Sg Americas Securities, LLC holds 475,862 shares of IMAB stock, worth $466,344. This represents 0.0% of its overall portfolio holdings.
Number of Shares
475,862Holding current value
$466,344% of portfolio
0.0%Shares
13 transactions
Others Institutions Holding IMAB
# of Institutions
34Shares Held
16.5MCall Options Held
0Put Options Held
14.5K-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$5.86 Million0.19% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC4.17MShares$4.08 Million3.04% of portfolio
-
Morgan Stanley New York, NY3.54MShares$3.47 Million0.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny431KShares$422,1840.0% of portfolio
-
Two Sigma Investments, LP New York, NY330KShares$323,6010.0% of portfolio
About I-Mab
- Ticker IMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,098,800
- Market Cap $81.4M
- Description
- I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...